RSPO fusion transcripts in colorectal cancer in Japanese population-Reference-Cited by-同舟云学术

RSPO fusion transcripts in colorectal cancer in Japanese population

Published:2014-05-22 Issue:8 Volume:41 Page:5375-5384
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Shinmura Kazuya,Kahyo Tomoaki,Kato Hisami,Igarashi Hisaki,Matsuura Shun,Nakamura Satoki,Kurachi Kiyotaka,Nakamura Toshio,Ogawa Hiroshi,Funai Kazuhito,Tanahashi Masayuki,Niwa Hiroshi,Sugimura Haruhiko

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11033-014-3409-x.pdf

Reference20 articles.

1. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, Ishikawa Y, Aburatani H, Niki T, Sohara Y, Sugiyama Y, Mano H (2007) Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448:561–566. doi: 10.1038/nature05945

2. Shinmura K, Kageyama S, Tao H, Bunai T, Suzuki M, Kamo T, Takamochi K, Suzuki K, Tanahashi M, Niwa H, Ogawa H, Sugimura H (2008) EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas. Lung Cancer 61:163–169. doi: 10.1016/j.lungcan.2007.12.013

3. Shinmura K, Kageyama S, Igarashi H, Kamo T, Mochizuki T, Suzuki K, Tanahashi M, Niwa H, Ogawa H, Sugimura H (2010) EML4-ALK fusion transcripts in immunohistochemically ALK-positive non-small cell lung carcinomas. Exp Ther Med 1:271–275. doi: 10.3892/etm_00000042

4. Takeuchi K, Soda M, Togashi Y, Suzuki R, Sakata S, Hatano S, Asaka R, Hamanaka W, Ninomiya H, Uehara H, Lim Choi Y, Satoh Y, Okumura S, Nakagawa K, Mano H, Ishikawa Y (2012) RET, ROS1 and ALK fusions in lung cancer. Nat Med 18:378–381. doi: 10.1038/nm.2658

5. Lipson D, Capelletti M, Yelensky R, Otto G, Parker A, Jarosz M, Curran JA, Balasubramanian S, Bloom T, Brennan KW, Donahue A, Downing SR, Frampton GM, Garcia L, Juhn F, Mitchell KC, White E, White J, Zwirko Z, Peretz T, Nechushtan H, Soussan-Gutman L, Kim J, Sasaki H, Kim HR, Park SI, Ercan D, Sheehan CE, Ross JS, Cronin MT, Jänne PA, Stephens PJ (2012) Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med 18:382–384. doi: 10.1038/nm.2673

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RSPO2 as Wnt signaling enabler: Important roles in cancer development and therapeutic opportunities;Genes & Diseases;2024-03

2. Nab-Paclitaxel and Gemcitabine as First-Line Treatment of Metastatic Ampullary Adenocarcinoma with a Novel R-Spondin2 RNA Fusion and NTRK3 Mutation;Biomedicines;2023-08-21

3. R-spondin-3 promotes proliferation and invasion of breast cancer cells independently of Wnt signaling;Cancer Letters;2023-08

4. Anti‐Pan‐Rspo Chimeric Protein‐Conjugated Albumin Nanoparticle Provides Promising Opportunities in Cancer Targeted Therapy;Advanced Healthcare Materials;2023-07-06

5. Incidence and clinical significance of 491 known fusion genes in a large cohort of Japanese patients with colorectal cancer;International Journal of Clinical Oncology;2023-04-06